Group 1 - The core viewpoint of the article highlights the financial performance and growth prospects of Meibang Technology, showcasing a revenue increase and strategic advancements in production capacity [1][2] - In 2024, Meibang Technology achieved a revenue of 540 million yuan, representing a year-on-year growth of 12.89%, with the fine chemical products segment contributing 501 million yuan, up 14.55% [1] - The company’s subsidiary, Meibang Zhongke, has initiated trial production of a new 30,000 tons/year tetrahydrofuran production line, which is expected to significantly enhance the supply capacity of core products and expand market share [1] Group 2 - Meibang Technology received multiple authoritative certifications in 2024, including recognition as a "Specialized and Innovative Small and Medium-sized Enterprise" and "High-tech Enterprise," reflecting its strong capabilities in green technology industrialization [2] - The company increased its R&D investment to 24.56 million yuan, a 12.21% increase year-on-year, and secured 16 national patents during the reporting period, enhancing its technological reserves [2] - Looking ahead, Meibang Technology aims to leverage its existing resources to further develop its fine chemicals and solutions business, particularly focusing on synthetic biology to drive sustainable long-term growth [2]
绿色科技赋能高质量发展 美邦科技24年度营收同比增长12.89%至5.4亿元